Splenic erythroid progenitors decrease TNF-α production by macrophages and reduce systemic inflammation in a mouse...

Area of Science:

• Immunology
• Gastroenterology
• Hematology

Background:

• Inflammatory bowel disease (IBD) involves systemic inflammation beyond the gut, leading to complications like cachexia.
• CD45, a pan-leukocyte marker and tyrosine phosphatase, plays a role in immune cell function.
• Understanding CD45's impact is crucial for IBD management.

Purpose of the Study:

• To investigate the role of CD45 in a mouse model of T cell transfer colitis.
• To determine how CD45 deficiency affects systemic inflammation and IBD-related complications.

Main Methods:

• Utilized a T cell transfer colitis mouse model using Rag1-deficient (RAGKO) and CD45-deficient RAGKO (CD45RAGKO) mice.
• Transferred CD25- CD45RBhigh CD4+ T cells into RAGKO and CD45RAGKO recipients.
• Assessed weight loss, systemic wasting, serum TNF-α levels, and splenic myeloid cell function.

Main Results:

• CD45RAGKO mice exhibited delayed weight loss and systemic wasting compared to RAGKO mice.
• Reduced serum TNF-α levels and TNF-α production by splenic myeloid cells were observed in CD45RAGKO mice.
• Increased erythroid progenitors in CD45RAGKO mice suppressed TNF-α production by splenic red pulp macrophages in a phagocytosis-dependent manner.

Conclusions:

• CD45 deficiency ameliorates systemic inflammation and cachexia in a mouse model of IBD.
• Erythroid progenitors possess immunosuppressive properties, potentially mitigating IBD-associated inflammation.
• This study reveals a novel mechanism involving erythroid cells in regulating splenic macrophage activity and IBD-related cachexia.